Compare stocks
Evaluate stocks side by side, to find the best fit for your investment goals.
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.
View stockOmaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two-thirds of the US, Union Pacific generated $24.5 billion of revenue in 2025 by hauling coal, industrial products, intermodal containers, agricultural goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one-fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.
View stockStock highlights
Stock name | Quanome Technologies | Union Pacific |
|---|---|---|
Last price | $0.33 | $304.20 |
Currency | USD | USD |
| $12M | $180B | |
| - | 23.56 | |
| -$0.37 | $12.82 | |
| 1.86 | 0.95 | |
| 0 | $5.56 | |
| 0 | 1.88% | |
Sector | Mobility | Mobility |
Employees | 27 | 28,658 |
Ticker | $QNME | $UNP |
Primary listing | NASDAQ | NYSE |
Performance
CumulativeRolling yearsLump sum investment
Invest in $QNME or $UNP on Lightyear
Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.